QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 25, no. 2 (2006): 491-500
doi: 10.1377/hlthaff.25.2.491
© 2006 by Project HOPE
 
New Online
 * McAllen, TX & Beyond: An Expert Roundtable
 * Geography & Reform
 * Medicaid or Insurance Exchange?
 * Siren Song of New GME
 * Public Plan Option: Pro & Con
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (5)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Morden, N. E.
* Articles by Garrison, L. P.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Morden, N. E.
* Articles by Garrison, L. P., Jr.
Related Collections
* Access To Care
* Health Promotion/Disease Prevention
* Health Reform
* Legal/Regulatory Issues
* Medicare
* Business Of Health
* Mental Health/Substance Abuse
* Pharmaceuticals
* Consumer Issues
* Elderly

DataWatch

Implications Of Part D For Mentally Ill Dual Eligibles: A Challenge For Medicare

Nancy E. Morden and Louis P. Garrison, Jr.

Through the Part D drug program, Medicare has assumed responsibility for the prescription drug needs of beneficiaries and, consequently, for an important component of mental health treatment: psychotropic drugs. Managing the prescription drug benefits of mentally ill dual eligibles could challenge this new program. Efforts to balance quality assurance and cost-effectiveness will be complicated by this population’s vulnerability and high level of health care need, the uncertainties surrounding optimal psychotropic drug use, and the economic incentives of prescription-only insurers. We discuss the details and policy implications of this challenge.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
J. M. Donohue, H. A. Huskamp, and S. H. Zuvekas
Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring?
Health Aff., May 1, 2009; 28(3): 746 - 759.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
K. Jones, C. Siegel, D. N. Bertollo, and J. Samuels
Impact of the Medicare Modernization Act on Dually Eligible Persons With Psychiatric Diagnoses: A New York State Case Study
Psychiatr Serv, April 1, 2009; 60(4): 512 - 519.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
H. Chen, A. Nwangwu, R. Aparasu, E. Essien, S. Sun, and K. Lee
The Impact of Medicare Part D on Psychotropic Utilization and Financial Burden for Community-Based Seniors
Psychiatr Serv, October 1, 2008; 59(10): 1191 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. M. Donohue and R. G. Frank
Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders
Psychiatr Serv, October 1, 2007; 58(10): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
J. M. Rosenberg
Overview of Medicare Part D prescription drug benefit: Potential implications for patients with psychotic disorders
Am. J. Health Syst. Pharm., January 15, 2007; 64(2_Supplement_1): S18 - S23.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2006 Project HOPE–The People-to-People Organization
Terms and Policies